Advertisement
Advertisement

FBLG

FBLG logo

FibroBiologics, Inc. Common Stock

1.16
USD
Sponsored
-0.08
-6.45%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.15

-0.01
-0.86%

FibroBiologics, Inc. Common Stock Profile

About

FibroBiologics Inc. is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics Inc. is based in HOUSTON.

Info & Links

CEO

Pete O�Heeron

Headquarters

455 E. MEDICAL CENTER BLVD, SUITE 300
HOUSTON, TX 77598, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.fibrobiologics.com

Auditor

WithumSmith+Brown, PC

Share holders

543

Employees

15

FibroBiologics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

5.99M

Enterprise Value

1.10M

Enterprise Value/EBITDA(ttm)

-0.07

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.75

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-785.84%

Return on Invested Capital(ttm)

-5428.04%

Return on Assets(ttm)

-170.69%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-15.82M

Net Income Available to Common(ttm)

-18.65M

Diluted EPS(ttm)

-8.40

Share Statistics

Beta (5Y Monthly)

1.07

52-Week Change

-93.15%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.38M

Dividend Yield

0.00%

Float4

3.06M

% Held by Insiders

13.00%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

4.89M

Total Cash Per Share(mrq)

1.45

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.61%

Quick Ratio(mrq)

3.61%

Book Value Per Share(mrq)

1.85

Cash Flow

Operating Cash Flow Per Share(ytd)

-7.34

Free Cash Flow(ytd)

-16.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement